Value of the systemic immune inflammation index in predicting the efficacy of neoadjuvant chemotherapy in patients with gastric cancer: a multicenter retrospective clinical study
The efficacy of neoadjuvant chemotherapy in patients with locally advanced gastric cancer has an important impact on prognosis, and the systemic immune inflammation index is a reliable biological indicator for the efficacy of this treatment.
Authors
- Fengying Wu (ORCID: https://orcid.org/0000-0001-5129-0528)
- Yuanyuan Jiao (ORCID: https://orcid.org/0009-0000-7192-2676)
- Arvind Sahu (ORCID: https://orcid.org/0000-0003-1664-2422)
- Min Chen (ORCID: https://orcid.org/0000-0002-6488-455X)
- Yang Li (ORCID: https://orcid.org/0000-0003-2530-7167)
- J. Lv (ORCID: https://orcid.org/0000-0002-8606-3656)
- Wei Wang (ORCID: https://orcid.org/0000-0002-3827-0474)
- Minghui Meng
Institutions
- Goulburn Valley Health (AU)
- The University of Melbourne (AU)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.21037/jgo-2025-423
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00